Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luisa Guidi

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Gastroenterology|September 10, 2011
Update on the management of inflammatory bowel disease: specific role of adalimumabLuisa Guidi, Daniela Pugliese, Alessandro Armuzzi
Therapeutics and Clinical Risk Management|February 12, 2009
Treatment of Crohn's disease with colony-stimulating factors: An overviewLuisa Guidi, Giammarco Mocci, Manuela Marzo, et al.
Drug Design, Development and Therapy|May 1, 2013
Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumabAlessandro Armuzzi, Daniela Pugliese, Olga Maria Nardone, et al.
World Journal of Gastroenterology|December 12, 2022
Glucagon-like peptide-2 analogues for Crohn's disease patients with short bowel syndrome and intestinal failureMarco Pizzoferrato, Pierluigi Puca, Sara Ennas, et al.
Mechanisms of Ageing and Development|April 26, 2003
DNA damage recognition and repair capacities in human naïve and memory T cells from peripheral blood of young and elderly subjectsSalvatore Scarpaci, Daniela Frasca, Paola Barattini, et al.
Journal of Crohn'S & Colitis|March 5, 2013
Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel diseaseGiammarco Mocci, Manuela Marzo, Alfredo Papa, et al.
Minerva Gastroenterologica E Dietologica|October 25, 2019
Therapeutic drug monitoring with vedolizumab in inflammatory bowel diseaseDaniela Pugliese, Giuseppe Privitera, Fabrizio Pizzolante, et al.
Ageing Research Reviews|June 5, 2004
Role of immune responsiveness and DNA repair capacity genes in ageingGino Doria, Paola Barattini, Salvatore Scarpaci, et al.
Drug, Healthcare and Patient Safety|February 20, 2016
Benefit-risk assessment of golimumab in the treatment of refractory ulcerative colitisDaniela Pugliese, Carla Felice, Rosario Landi, et al.
European Radiology|March 23, 2006
Multidetector CT enteroclysis versus barium enteroclysis with methylcellulose in patients with suspected small bowel diseaseLaura Maria Minordi, Amorino Vecchioli, Luisa Guidi, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Gastroenterology|September 10, 2011
Update on the management of inflammatory bowel disease: specific role of adalimumabLuisa Guidi, Daniela Pugliese, Alessandro Armuzzi
Therapeutics and Clinical Risk Management|February 12, 2009
Treatment of Crohn's disease with colony-stimulating factors: An overviewLuisa Guidi, Giammarco Mocci, Manuela Marzo, et al.
Drug Design, Development and Therapy|May 1, 2013
Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumabAlessandro Armuzzi, Daniela Pugliese, Olga Maria Nardone, et al.
World Journal of Gastroenterology|December 12, 2022
Glucagon-like peptide-2 analogues for Crohn's disease patients with short bowel syndrome and intestinal failureMarco Pizzoferrato, Pierluigi Puca, Sara Ennas, et al.
Mechanisms of Ageing and Development|April 26, 2003
DNA damage recognition and repair capacities in human naïve and memory T cells from peripheral blood of young and elderly subjectsSalvatore Scarpaci, Daniela Frasca, Paola Barattini, et al.
Journal of Crohn'S & Colitis|March 5, 2013
Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel diseaseGiammarco Mocci, Manuela Marzo, Alfredo Papa, et al.
Minerva Gastroenterologica E Dietologica|October 25, 2019
Therapeutic drug monitoring with vedolizumab in inflammatory bowel diseaseDaniela Pugliese, Giuseppe Privitera, Fabrizio Pizzolante, et al.
Ageing Research Reviews|June 5, 2004
Role of immune responsiveness and DNA repair capacity genes in ageingGino Doria, Paola Barattini, Salvatore Scarpaci, et al.
Drug, Healthcare and Patient Safety|February 20, 2016
Benefit-risk assessment of golimumab in the treatment of refractory ulcerative colitisDaniela Pugliese, Carla Felice, Rosario Landi, et al.
European Radiology|March 23, 2006
Multidetector CT enteroclysis versus barium enteroclysis with methylcellulose in patients with suspected small bowel diseaseLaura Maria Minordi, Amorino Vecchioli, Luisa Guidi, et al.
Pageof 7